Exploratory/Developmental Award
2012 (Cycle 21)
| Oxidative Stress/Inflammation in Pulmonary Disease | 2012 (Cycle 21) | $415,004 |
| Scripps Research Institute | Early Diagnosis/Pathogenesis | |
| TITF1 signature biomarkers for early lung cancer detection | 2012 (Cycle 21) | $343,830 |
| Stanford University | Early Diagnosis/Pathogenesis | |
| Virtual Intervention for Lung Cancer Stigma | 2012 (Cycle 21) | $219,000 |
| University of California, San Francisco | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
| Improving Tobacco Dependence Treatment in the Addictions | 2012 (Cycle 21) | $219,000 |
| University of California, San Francisco | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
| Screening Smokers for Depression Using California's Helpline | 2012 (Cycle 21) | $219,000 |
| University of California, San Diego | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
| Identifying new markers for diagnosis and treatment of SCLC | 2012 (Cycle 21) | $219,000 |
| University of California, San Francisco | Early Diagnosis/Pathogenesis | |
| Imaging SHS Deposition in the Airways of Sprague-Dawley Rats | 2012 (Cycle 21) | $218,999 |
| University of California, Davis | Environmental Exposure/Toxicology | |
| Cigarette Producer Responsibility Project | 2012 (Cycle 21) | $239,401 |
| Cigarette Butt Pollution Project | Regulatory Science/New Products | |
2011 (Cycle 20)
| The effects of stereotype threat on smoking behavior | 2011 (Cycle 20) | $248,932 |
| University of California, Los Angeles | Public Health, Public Policy, and Economics | |
| Proteomic Mapping of Human Lung Tumor Endothelium | 2011 (Cycle 20) | $487,500 |
| Proteomics Research Institute for Systems Medicine | Cancer | |
| Leveraging Adjuvants for Improved Nicotine Vaccines | 2011 (Cycle 20) | $421,413 |
| Scripps Research Institute | Tobacco-Use Prevention and Cessation | |
| Design of Complement Inhibitors for Cardiovascular Disease | 2011 (Cycle 20) | $250,000 |
| University of California, Riverside | Cardiovascular Disease | |
| Effect of Smoking on Vascular Calcification in COPD | 2011 (Cycle 20) | $352,361 |
| LA Biomedical Research Institute at Harbor-UCLA Medical Center | Cardiovascular Disease | |
| Genome-wide mapping of smoke-induced DNA damage and mutation | 2011 (Cycle 20) | $420,000 |
| Beckman Research Institute of the City of Hope | Cancer | |
| Electronic Cigarettes: Are They Safe? | 2011 (Cycle 20) | $250,000 |
| University of California, Riverside | General Biomedical Science | |
| Sirtuin deacetylase and RAS-dependent cancers | 2011 (Cycle 20) | $420,000 |
| Beckman Research Institute of the City of Hope | Cancer | |
| SMART:Sequential Motion Adaptation to Improve Lung Cancer RT | 2011 (Cycle 20) | $250,000 |
| University of California, Los Angeles | Cancer | |
| Nicotine Receptor in Nicotine Dependence | 2011 (Cycle 20) | $405,000 |
| California Institute of Technology | Nicotine Dependence | |
| Tobacco Cessation Interventions for Mental Health Patients | 2011 (Cycle 20) | $353,356 |
| Veterans Medical Research Foundation | Tobacco-Use Prevention and Cessation | |
| Tobacco-use by LGBTQ youth: prevalence and correlates | 2011 (Cycle 20) | $304,650 |
| Education Training and Research Associates, Inc. | Tobacco-Use Prevention and Cessation | |
| Lung cancer detection by methylation-preserving PCR | 2011 (Cycle 20) | $324,825 |
| University of Southern California | Cancer | |
| Role for fibroblasts in the chronic immune response in COPD | 2011 (Cycle 20) | $250,000 |
| University of California, San Francisco | Pulmonary Disease | |
| Selective Lung Cancer Treatment with Small Conditional RNAs | 2011 (Cycle 20) | $410,000 |
| California Institute of Technology | Cancer | |
2010 (Cycle 19)
| SOX-2 knockdown in stem cells prevents lung tumor recurrence | 2010 (Cycle 19) | $474,750 |
| Scripps Research Institute | Cancer | |
| Targeted nanodelivery of anti-inflammatory drugs | 2010 (Cycle 19) | $482,749 |
| Proteomics Research Institute for Systems Medicine | Pulmonary Disease | |
| Menthol Cigarette Smokers:nAChR Levels and Treatment Effects | 2010 (Cycle 19) | $269,460 |
| Brentwood Biomedical Research Institute | Nicotine Dependence | |
| Genotoxicity of Thirdhand Smoke and Aged Secondhand Smoke | 2010 (Cycle 19) | $427,267 |
| Lawrence Berkeley National Laboratory | General Biomedical Science | |
| Chromosome 9p21.3 in tobacco related vascular diseases | 2010 (Cycle 19) | $360,724 |
| Stanford University | Cardiovascular Disease | |
| Apoptotic cell clearance and Tobacco Induced COPD | 2010 (Cycle 19) | $250,000 |
| University of California, San Diego | Pulmonary Disease | |
| Novel Susceptibility Factors in Lung Cancer Evolution | 2010 (Cycle 19) | $400,000 |
| Stanford University | Cancer | |
| Using Adultborn Neurons to Combat Nicotine Relapse | 2010 (Cycle 19) | $250,000 |
| University of California, San Diego | Nicotine Dependence | |
| Understanding nicotinic receptor subtype specificity | 2010 (Cycle 19) | $361,036 |
| California Institute of Technology | Nicotine Dependence | |
| Dynamic Imaging of Sodium Channels in Metastatic Lung Cancer | 2010 (Cycle 19) | $400,000 |
| Stanford University | Cancer | |
| Effects of THS on cell and molecular mechanisms of healing | 2010 (Cycle 19) | $250,000 |
| University of California, Riverside | General Biomedical Science | |
| Enhancing mTOR-targeted lung cancer therapy | 2010 (Cycle 19) | $474,750 |
| Scripps Research Institute | Cancer | |
| Fbxo2: a master regulator of lung cancer metastasis? | 2010 (Cycle 19) | $477,500 |
| The Burnham Institute for Medical Research | Cancer | |
| Secondhand Smoke and Human Prenatal Development | 2010 (Cycle 19) | $250,000 |
| University of California, Riverside | General Biomedical Science | |
| A Family Intervention to Reduce Smoking in Vietnamese Men | 2010 (Cycle 19) | $249,977 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
2009 (Cycle 18)
| Regulation of biased PAR1 signaling by ubiquitination | 2009 (Cycle 18) | $250,000 |
| University of California, San Diego | General Biomedical Science | |
| An atypical nicotine receptor: target for anti-angiogenics? | 2009 (Cycle 18) | $385,707 |
| Stanford University | Cardiovascular Disease | |
| Developing A Menthol-Centric Smoking Cessation Intervention | 2009 (Cycle 18) | $353,750 |
| Charles R. Drew University of Medicine & Science | Tobacco-Use Prevention and Cessation | |
| Pro-inflammatory sPLA2, integrins, and smoking | 2009 (Cycle 18) | $250,000 |
| University of California, Davis | Cardiovascular Disease | |
| Tobacco Industry Influence on Policy Making | 2009 (Cycle 18) | $248,003 |
| University of California, San Francisco | Public Health, Public Policy, and Economics | |
| Toxicity of Harm Reduction Products on Human Development | 2009 (Cycle 18) | $250,000 |
| University of California, Riverside | General Biomedical Science | |
| The effect of nicotine on airway inflammation | 2009 (Cycle 18) | $406,250 |
| University of Southern California | Pulmonary Disease | |
| Nicotine and Abdominal Aortic Aneurysms | 2009 (Cycle 18) | $400,534 |
| Stanford University | Cardiovascular Disease | |
| Novel Drugs for Lung Cancer | 2009 (Cycle 18) | $354,000 |
| Veterans Medical Research Foundation | Cancer | |
| DNA Adducts Arising from Tobacco-derived N-nitrosamines | 2009 (Cycle 18) | $250,000 |
| University of California, Riverside | General Biomedical Science | |
| Notch promotes arteriogenesis in smoke-related limb ischemia | 2009 (Cycle 18) | $250,000 |
| University of California, San Francisco | Cardiovascular Disease | |
| Genome-specific synthetic lethal targeting in lung cancer | 2009 (Cycle 18) | $400,000 |
| Stanford University | Cancer | |
| Lung Development, Tobacco Smoke and Sensitivity to Infection | 2009 (Cycle 18) | $250,000 |
| University of California, Davis | Pulmonary Disease | |
| Sympathoexcitatory Effect of Tobacco in Premenopausal Women | 2009 (Cycle 18) | $245,492 |
| University of California, Los Angeles | Cardiovascular Disease | |
| Corepressors, TZDs, and tobacco-induced lung inflammation | 2009 (Cycle 18) | $249,587 |
| University of California, Davis | Pulmonary Disease | |
| Bar Interventions to Decrease Young Adult and LGBT Smoking | 2009 (Cycle 18) | $249,459 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
| Autophagy and cell fate in K-Ras mutant lung cancer cells | 2009 (Cycle 18) | $250,000 |
| University of California, San Francisco | Cancer | |
| Low Frequency Smoking Among Latinos | 2009 (Cycle 18) | $249,863 |
| University of California, San Diego | Tobacco-Use Prevention and Cessation | |
| Quantitative Proteomics of Oral Precancer Progression | 2009 (Cycle 18) | $249,605 |
| University of California, Los Angeles | Cancer | |
| Active and Passive Smoking and Risk of Colorectal Cancer | 2009 (Cycle 18) | $324,035 |
| Cancer Prevention Institute of California | Epidemiology | |
| Novel Therapy Sensitization Strategy for Lung Cancer | 2009 (Cycle 18) | $450,000 |
| Torrey Pines Institute for Molecular Studies | Cancer | |
| Informing Smoking Interventions for CA University Students | 2009 (Cycle 18) | $353,950 |
| Veterans Medical Research Foundation | Tobacco-Use Prevention and Cessation | |
| Nicotine/norharmane as a model of tobacco dependence | 2009 (Cycle 18) | $248,962 |
| University of California, Irvine | Nicotine Dependence | |
| Does Maternal Smoking Impair Neonatal Control of Breathing? | 2009 (Cycle 18) | $250,000 |
| University of California, Los Angeles | Pulmonary Disease | |
| Role of EphA3 receptor mutations in lung cancer | 2009 (Cycle 18) | $477,500 |
| The Burnham Institute for Medical Research | Cancer | |
| Modeling and mapping changes in tobacco outlet density | 2009 (Cycle 18) | $388,520 |
| Stanford University | Public Health, Public Policy, and Economics | |
| Immunotargeting lung cancer | 2009 (Cycle 18) | $487,500 |
| Proteomics Research Institute for Systems Medicine | Cancer | |
| Economic impact of smoking for persons with mental disorders | 2009 (Cycle 18) | $249,933 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
| Cigarette Smoke Exposure In Utero: Neonatal Immunity | 2009 (Cycle 18) | $250,000 |
| University of California, San Diego | Pulmonary Disease | |
| A new approach to anti-angiogenic therapy in lung cancer | 2009 (Cycle 18) | $407,935 |
| Stanford University | Cancer | |
| Exploring retailer abandonment of tobacco sales | 2009 (Cycle 18) | $250,000 |
| University of California, San Francisco | Public Health, Public Policy, and Economics | |